Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory action/ inspection
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals has filed a disclosure with the stock exchanges under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, relating to a regulatory action or inspection. The company has informed exchanges about the matter as required by listing rules. Specific details of the action, the regulator involved, and the nature of the inspection are to be confirmed from the full filing. Further details on the impact, if any, on business operations are awaited.
The disclosure itself is a compliance requirement and does not immediately indicate financial impact. Shareholders should watch for further details on the nature of the regulatory action to assess potential implications for the stock or company operations.